The Evaluation of Left Ventricular Function for Patients Being Considered For, or Receiving Trastuzumab (Herceptin) Therapy
British Journal of Cancer- United Kingdom
doi 10.1038/sj.bjc.6603340
Full Text
Abstract
Available in
Date
October 24, 2006
Authors
Publisher
Springer Science and Business Media LLC